keyword
MENU ▼
Read by QxMD icon Read
search

BPH high volume

keyword
https://www.readbyqxmd.com/read/27900218/a-prospective-randomised-controlled-study-comparing-bipolar-plasma-vaporisation-of-the-prostate-to-monopolar-transurethral-resection-of-the-prostate
#1
Ahmed M Elsakka, Hssan H Eltatawy, Khaled H Almekaty, Ahmed R Ramadan, Tarik A Gameel, Yasser Farahat
OBJECTIVES: To compare the safety and efficacy of bipolar transurethral plasma vaporisation (B-TUVP) as an alternative to the 'gold standard' monopolar transurethral resection of the prostate (M-TURP) for the treatment of benign prostatic hyperplasia (BPH) in a prospective randomised controlled study. PATIENTS AND METHODS: In all, 82 patients indicated for prostatectomy were assigned to two groups, group I (40 patients) underwent B-TUVP and group II (42 patients) underwent M-TURP...
December 2016: Arab Journal of Urology
https://www.readbyqxmd.com/read/27817158/a-pet-mri-study-towards-finding-the-optimal-18-f-fluciclovine-pet-protocol-for-detection-and-characterisation-of-primary-prostate-cancer
#2
Mattijs Elschot, Kirsten M Selnæs, Elise Sandsmark, Brage Krüger-Stokke, Øystein Størkersen, May-Britt Tessem, Siver A Moestue, Helena Bertilsson, Tone F Bathen
PURPOSE: [(18)F]Fluciclovine PET imaging shows promise for the assessment of prostate cancer. The purpose of this PET/MRI study is to optimise the PET imaging protocol for detection and characterisation of primary prostate cancer, by quantitative evaluation of the dynamic uptake of [(18)F]Fluciclovine in cancerous and benign tissue. METHODS: Patients diagnosed with high-risk primary prostate cancer underwent an integrated [(18)F]Fluciclovine PET/MRI exam before robot-assisted radical prostatectomy with extended pelvic lymph node dissection...
November 5, 2016: European Journal of Nuclear Medicine and Molecular Imaging
https://www.readbyqxmd.com/read/27615435/robotic-assisted-simple-prostatectomy-rasp-versus-holmium-laser-enucleation-of-the-prostate-holep-for-lower-urinary-tract-symptoms-in-patients-with-large-volume-prostates-100-ml-a-comparative-analysis-from-a-high-volume-center
#3
Paolo Umari, Nicola Fossati, Giorgio Gandaglia, Morgan Pokorny, Ruben De Groote, Nicolas Geurts, Marijn Goossens, Peter Schatterman, Geert De Naeyer, Alexandre Mottrie
OBJECTIVE: To report a comparative analysis of Robotic-assisted Simple Prostatectomy (RASP) versus Holmium Laser Enucleation of Prostate (HoLEP) in Benign Prostatic Hyperplasia (BPH) patients with large volume prostates (>100ml). MATERIAL AND METHODS: 81 patients underwent RASP and 45 underwent HoLEP over a 7-year period. Patients were preoperatively assessed with transrectal ultrasound and uroflowmetry. Functional parameters were assessed postoperatively during the follow-up...
September 8, 2016: Journal of Urology
https://www.readbyqxmd.com/read/27601858/an-observational-study-of-the-association-between-androgenetic-alopecia-and-size-of-the-prostate
#4
Kanagaraj Ramsamy, Radhakrishnan Subramaniyan, Anjan Kumar Patra
INTRODUCTION: Androgenetic alopecia (AGA) is characterized by miniaturization of the hair follicle, leading to vellus transformation of the terminal hair follicle. It is caused by interactions between androgens, several genes, and environmental factors with hair follicles. Benign prostatic hyperplasia (BPH) is highly prevalent among elderly men but infrequent in those younger than 40 years. Because both entities share a common pathogenesis and AGA manifests before the onset of BPH, there could be an association between AGA and BPH...
April 2016: International Journal of Trichology
https://www.readbyqxmd.com/read/27524886/three-year-outcome-analysis-of-alpha-1-blocker-naftopidil-for-patients-with-benign-prostatic-hyperplasia-in-a-prospective-multicenter-study-in-japan
#5
Naoya Masumori, Taiji Tsukamoto, Akihiko Shibuya, Noriomi Miyao, Yasuharu Kunishima, Akihiko Iwasawa
PURPOSE: Our aim was to prospectively analyze the 3-year outcomes of naftopidil treatment for patients with benign prostatic hyperplasia (BPH), including those who dropped out during follow-up and had retreatment for BPH after termination of the drug within 3 years. PATIENTS AND METHODS: Naftopidil, 50 mg/d or 75 mg/d, was given to 117 patients having BPH aged 50 years and older who had international prostate symptom scores (IPSS) ≥8. They were prospectively followed for 3 years with periodic evaluation...
2016: Patient Preference and Adherence
https://www.readbyqxmd.com/read/27503267/prostate-specific-extracellular-vesicles-as-a-novel-biomarker-in-human-prostate-cancer
#6
Yong Hyun Park, Hyun Woo Shin, Ae Ryang Jung, Oh Sung Kwon, Yeong-Jin Choi, Jaesung Park, Ji Youl Lee
Extracellular vesicles (EVs) may play an important role in cancer development and progression. We aimed to investigate the prognostic potential of prostate-specific EVs in prostate cancer (PCa) patients. Plasma and prostate tissue were collected from patients who underwent surgery for PCa (n = 82) or benign prostatic hyperplasia (BPH, n = 28). To analyze the quantity of EVs in prostate, we performed transmission electron microscopy (TEM), immuno-TEM with CD63 and prostate-specific membrane antigen (PSMA), and immunofluorescence staining...
2016: Scientific Reports
https://www.readbyqxmd.com/read/27489744/benign-prostatic-hyperplasia-metabolic-syndrome-and-androgenic-alopecia-is-there-a-possible-relationship
#7
Naglaa F Agamia, Tamer Abou Youssif, Abeer El-Hadidy, Amr El-Abd
OBJECTIVE: To evaluate the incidence of benign prostatic hyperplasia (BPH) and metabolic syndrome in patients with androgenetic alopecia (AGA) in comparison with those with no AGA, as several previous studies have reported inconsistent results of an association between metabolic syndrome and BPH with AGA. PATIENTS SUBJECTS AND METHODS: This cross-sectional study included 400 participants, divided into 300 patients diagnosed with AGA, with different grades according to Norwood-Hamilton classification, and 100 control subjects with no AGA...
June 2016: Arab Journal of Urology
https://www.readbyqxmd.com/read/27418113/increased-urinary-adenosine-triphosphate-in-patients-with-bladder-outlet-obstruction-due-to-benign-prostate-hyperplasia
#8
Miguel Silva-Ramos, Isabel Silva, José Carlos Oliveira, Paulo Correia-de-Sá
BACKGROUND: Diagnosis of bladder outflow obstruction (BOO) in patients with lower urinary tract (LUT) symptoms is challenging without using invasive urodynamic tests. Recently, we showed in vitro that urothelial strips from patients with benign prostatic hyperplasia (BPH) release more ATP than controls. Here, we tested whether urinary ATP can be used as a wall tension transducer non-invasive biomarker to detect BOO in patients with BPH. METHODS: 79 male patients with BOO and 22 asymptomatic controls were recruited prospectively...
November 2016: Prostate
https://www.readbyqxmd.com/read/27363064/high-incidence-of-incidental-prostate-cancer-in-transurethral-resection-of-prostate-specimens-in-china-the-value-of-pathologic-review
#9
Jian Lin, Xi Yu, Xinyu Yang, Jie Jin, Liqun Zhou, Libo Liu, Jinwei Su, Yanyan Li, Meixia Shang
OBJECTIVE: To identify the incidence and clinicopathologic features of prostate cancer incidentally detected in patients undergoing transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH), and to estimate the clinical value of pathologic review of all TURP specimens. STUDY DESIGN: A pathologic review was performed on all TURP specimens for each patient from May 1, 2004, to June 30, 2014, in our institute. A total of 1,024 men (ages 46-98) were identified by pathology specimen...
February 2016: Analytical and Quantitative Cytopathology and Histopathology
https://www.readbyqxmd.com/read/27358847/diagnosis-and-treatment-patterns-of-male-lower-urinary-tract-symptoms-suggestive-of-benign-prostatic-hyperplasia-in-murjani-general-hospital-central-kalimantan-indonesia
#10
Robert Adrianto Raharjo
BACKGROUND: The aim of this study was to describe the diagnosis and treatment patterns of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) and evaluate their appropriateness in an area without an urologist and with limited resources, such as the area covered by Murjani General Hospital, Sampit, Indonesia. METHODS: This descriptive study used data collected from medical records of patients who were diagnosed with LUTS suggestive of BPH in Murjani General Hospital between September 2013 and August 2015...
June 2016: Prostate International
https://www.readbyqxmd.com/read/27336586/does-inflammation-mediate-the-obesity-and-bph-relationship-an-epidemiologic-analysis-of-body-composition-and-inflammatory-markers-in-blood-urine-and-prostate-tissue-and-the-relationship-with-prostate-enlargement-and-lower-urinary-tract-symptoms
#11
Jay H Fowke, Tatsuki Koyama, Oluwole Fadare, Peter E Clark
BACKGROUND: BPH is a common disease associated with age and obesity. However, the biological pathways between obesity and BPH are unknown. Our objective was to investigate biomarkers of systemic and prostate tissue inflammation as potential mediators of the obesity and BPH association. METHODS: Participants included 191 men without prostate cancer at prostate biopsy. Trained staff measured weight, height, waist and hip circumferences, and body composition by bioelectric impedance analysis...
2016: PloS One
https://www.readbyqxmd.com/read/27322582/prostatic-artery-embolization-a-promising-technique-in-the-treatment-of-high-risk-patients-with-benign-prostatic-hyperplasia
#12
Ahmed H Gabr, Mohamed F Gabr, Basheer N Elmohamady, Abul-Fotouh Ahmed
INTRODUCTION: Prostatic artery embolization (PAE) has recently started to be viewed as a promising technology that could be an alternative to different treatment options of benign prostatic hyperplasia (BPH), especially in high-risk patients. The aim of our study was to evaluate the efficacy and safety of PAE in BPH patients who are at high risk for surgery and/or anesthesia. MATERIALS AND METHODS: Between June 2013 and February 2015, BPH patients >50 years with lower urinary tract symptoms (LUTS) refractory to BPH-related medical therapy or had an indwelling urethral catheter due to refractory urine retention were prospectively enrolled in the study...
June 21, 2016: Urologia Internationalis
https://www.readbyqxmd.com/read/27294802/trends-in-simple-prostatectomy-for-benign-prostatic-hyperplasia
#13
REVIEW
Joseph J Pariser, Vignesh T Packiam, Melanie A Adamsky, Gregory T Bales
The definitive treatment for symptomatic large volume (>80 mL) benign prostatic hyperplasia (BPH) is simple prostatectomy (SP). This can be performed by utilizing a retropubic, suprapubic, or a combined approach. The latter two approaches allow for the management of concomitant bladder diverticulum or stones through the same incision. Each approach affords unique technical strengths and weaknesses that must be considered in light of patient characteristics and concomitant pathology. SP allows for removal of the entire prostatic adenoma while obviating some of the neurovascular and continence issues that can arise from radical prostatectomy...
August 2016: Current Urology Reports
https://www.readbyqxmd.com/read/27243216/lps-tlr4-signaling-enhances-tgf-%C3%AE-response-through-downregulating-bambi-during-prostatic-hyperplasia
#14
Yao He, Zhenyu Ou, Xiang Chen, Xiongbing Zu, Longfei Liu, Yuan Li, Zhenzhen Cao, Minfeng Chen, Zhi Chen, Hequn Chen, Lin Qi, Long Wang
Compelling evidence suggests that benign prostatic hyperplasia (BPH) development involves accumulation of mesenchymal-like cells derived from the prostatic epithelium by epithelial-mesenchymal transition (EMT). Transforming growth factor (TGF)-β induces EMT phenotypes with low E-cadherin and high vimentin expression in prostatic epithelial cells. Here we report that LPS/TLR4 signalling induces down-regulation of the bone morphogenic protein and activin membrane-bound inhibitor (BAMBI), which enhances TGF-β signalling in the EMT process during prostatic hyperplasia...
2016: Scientific Reports
https://www.readbyqxmd.com/read/27225056/the-effect-of-asymptomatic-histological-prostatitis-on-sexual-function-and-lower-urinary-tract-symptoms
#15
Ahmet Urkmez, Ozgur Haki Yuksel, Fatih Uruc, Serkan Akan, Caglar Yildirim, Aytac Sahin, Ayhan Verit
OBJECTIVE: Prostatitis affects 10-14% of men of all ages and ethnicities. More than 50% of the men experience episodes of prostatitis at one time of their lives. Patients with CP typically have longlasting genitourinary/pelvic pain and obstructive and/or irritative voiding symptoms. Sexual dysfunction and psychological symptoms are frequently added to these symptoms. We also investigated the relationship between sexual functions, and lower urinary system symptoms, and asymptomatic histological prostatitis detected on transrectal ultrasound-guided (TRUS) biopsy performed with the indication of high PSA levels...
May 2016: Archivos Españoles de Urología
https://www.readbyqxmd.com/read/27031406/design-synthesis-and-biological-evaluation-of-indoline-and-indole-derivatives-as-potent-and-selective-%C3%AE-1a-adrenoceptor-antagonists
#16
Fei Zhao, Jing Li, Ying Chen, Yanxin Tian, Chenglin Wu, Yanan Xie, Yu Zhou, Jiang Wang, Xin Xie, Hong Liu
A series of indoline and indole derivatives were designed, synthesized, and evaluated as selective α1A-adrenergic receptor (α1A-AR) antagonists for the treatment of benign prostatic hyperplasia (BPH). In this study, two highly selective and potent α1A-AR antagonists, compounds (R)-14r (IC50 = 2.7 nM, α1B/α1A = 640.1, α1D/α1A = 408.2) and (R)-23l (IC50 = 1.9 nM, α1B/α1A = 1506, α1D/α1A = 249.6), which exhibited similar activities and better selectivities in cell-based calcium assays as compared with the marketed drug silodosin (IC50 = 1...
April 28, 2016: Journal of Medicinal Chemistry
https://www.readbyqxmd.com/read/27009501/different-lasers-in-the-treatment-of-benign-prostatic-hyperplasia-a-network-meta-analysis
#17
Xingming Zhang, Pengfei Shen, Qiying He, Xiaoxue Yin, Zhibin Chen, Haojun Gui, Kunpeng Shu, Qidun Tang, Yaojing Yang, Xiuyi Pan, Jia Wang, Ni Chen, Hao Zeng
All available surgical treatments for benign prostatic hyperplasia (BPH) have their individual advantages or disadvantages. However, the lack of head-to-head studies comparing different surgeries makes it unavailable to conduct direct analysis. To compare the efficacy and safety among different lasers and transurethral resection of prostate (TURP) for BPH, randomized controlled trials were searched in MEDLINE, EMBASE, Cochrane library, WHO International Clinical Trial Registration Platform, and Clinical Trial...
2016: Scientific Reports
https://www.readbyqxmd.com/read/26940981/long-term-outcome-following-thulium-vaporesection-of-the-prostate
#18
Haiyi Yu, Zhaocun Zhang, Yaofeng Zhu, Jun Chen, Xuewen Jiang, Hui Meng, Benkang Shi
BACKGROUND: The continuous wave 2-μm Thulium Laser has been introduced as potential technology with both high efficiency and safe practice; although little data have been shown regarding the long-term outcomes. OBJECTIVE: To analyze the long-term outcomes after thulium vaporesection of the prostate (ThuVaRP). METHODS: ThuVaRP was performed using the continuous wave, 2-μm Thulium: YAG laser at 70 W. The perioperative and post-operative follow-up data were analyzed...
July 2016: Lasers in Surgery and Medicine
https://www.readbyqxmd.com/read/26892901/bipolar-versus-monopolar-transurethral-resection-of-the-prostate-for-benign-prostatic-hyperplasia-safe-in-patients-with-high-surgical-risk
#19
Er J Yang, Hao Li, Xin B Sun, Li Huang, Li Wang, Xiao X Gong, Yong Yang
Here, we compared the effects of bipolar and monopolar transurethral resection of the prostate (B-TURP, M-TURP) for treating elderly patients (≥75 years) with benign prostatic hyperplasia(BPH) who had internal comorbidities. Eligible BPH patients were aged ≥75 years and had at least one internal comorbidity. In this open-label, prospective trial, patients were assigned to B-TURP (n = 75) and M-TURP (n = 88) groups. Data on prostate volume (PV), urination, and time during perioperative period were compared; data associated with urination and complications at one year postoperatively were also compared...
2016: Scientific Reports
https://www.readbyqxmd.com/read/26877233/-greenlight-%C3%A2-photoselective-vaporization-of-the-prostate-contemporary-practices-in-france
#20
B Pradere, B Peyronnet, G Leonard, V Misrai, F Bruyère
INTRODUCTION: Photovaporization of the prostate by the Greenlight(®) laser (GL) has been strongly developed this past few years in France, representing nearly 30% of surgery for BPH, making France the second GL user worldwide after USA. The objective of this study was to assess the French surgeons practices with the Greenlight(®) laser. MATERIAL AND METHODS: During the 4th meeting of French Greenlight(®) users group (GUGL), was proposed a questionnaire on the management of patients and the GL technique...
March 2016: Progrès en Urologie
keyword
keyword
85332
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"